NLRP3 inflammasome via IL-1β regulates PCSK9 secretion

Area of Science:

• Cardiovascular Biology
• Inflammation Research
• Metabolic Disease

Background:

• Atherogenesis involves both PCSK9 and the NLRP3 inflammasome.
• The interplay between NLRP3 inflammasome, IL-1β, and PCSK9 is crucial in cardiovascular disease development.

Purpose of the Study:

• To investigate if the NLRP3 inflammasome induces PCSK9 secretion via IL-1β.
• To elucidate the mechanistic link between NLRP3 inflammasome activation and PCSK9 production.

Main Methods:

• Utilized mouse peritoneal macrophages and various tissues (liver, kidney, small intestine).
• Employed gene deletion mice models to dissect the NLRP3 inflammasome pathway.
• Conducted studies in mice fed high-fat diets versus standard diets.

Main Results:

• NLRP3 inflammasome components (ASC, Caspase-1, IL-18, IL-1β) are involved in PCSK9 secretion.
• IL-1β plays a more critical role than IL-18 in PCSK9 induction.
• High-fat diet increases NLRP3 expression and PCSK9 secretion, an effect blunted in IL-1β deficient mice.

Conclusions:

• NLRP3 inflammasome, predominantly via IL-1β, is a key regulator of PCSK9 secretion.
• This pathway is particularly significant in the context of high-fat diet-induced metabolic changes relevant to atherogenesis.